SAN FRANCISCO–(BUSINESS WIRE)–Today PAX Labs is unveiling its new Era ProTM, the world’s most sophisticated cannabis vaporizer device. Built with safety at its core, the Era Pro puts transparency and control directly into the hands of consumers, setting the gold standard for quality and delivering the best experience every single time. Smartest Vape Technology Era…
DetailsTORONTO–(BUSINESS WIRE)–Halo Labs Inc. (“Halo” or the “Company”) (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) is pleased to announce that Bophelo Bioscience & Wellness (“Bophelo”) has signed a strategic alliance and seed purchase agreement with OG DNA Genetics Inc. (“DNA Genetics” or “DNA”), to give the Bophelo exclusive rights to develop new and existing DNA Genetics’…
DetailsTORONTO–(BUSINESS WIRE)–FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) (“FSD Pharma” or the “Company”) today announced that its Class B Subordinate Voting Shares (the “Shares”) have been approved for listing on the NASDAQ Capital Market (“NASDAQ”) under the symbol ‘HUGE’. Trading on the NASDAQ is expected to commence at market open on Thursday, January…
DetailsLOS ANGELES–(BUSINESS WIRE)–Xtraction Services Holding Corp., (“Xtraction Services”, “XS” or the “Company“) (CSE:XS) a specialty finance company engaged in equipment leasing in the United States, announced today that effective December 31, 2019, the Company has completed a transaction (the “Transaction”) with a vendor and former partner and its staff (together, the “Vendors”), whereby all of…
DetailsSEATTLE–(BUSINESS WIRE)–Alpine Immune Sciences, Inc. (NASDAQ:ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for cancer and autoimmune/inflammatory diseases, today announced the company will present a poster at the 2020 Crohn’s & Colitis Congress taking place January 23-25, 2020, in Austin, Texas. Details of the presentation are as follows: Presentation Title: ALPN-101, A…
DetailsPETACH TIKVA, Israel–(BUSINESS WIRE)–Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE:CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver diseases, issued a Letter to Shareholders from the Company’s Chief Executive Officer, Pnina Fishman, Ph.D. Dear Can-Fite Shareholders, We made significant progress in our drug development programs during…
DetailsMONCTON, New Brunswick–(BUSINESS WIRE)–Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, announced today it will report earnings results for its first quarter fiscal 2020 ended November 30, 2019 on Tuesday, January 14th after market close. The Company will host a…
DetailsTORONTO–(BUSINESS WIRE)–Halo Labs Inc. (“Halo” or the “Company”) (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) is pleased to announce that Bophelo Bioscience & Wellness (“Bophelo”) has signed a strategic alliance and seed purchase agreement with OG DNA Genetics Inc. (“DNA Genetics” or “DNA”), to give the Bophelo exclusive rights to develop new and existing DNA Genetics’…
DetailsLOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”), a national investors rights law firm, announces that a class action lawsuit has been filed on behalf of investors that purchased Trulieve Cannabis Corp. (“Trulieve” or the “Company”) (OTC: TCNNF) securities between September 25, 2018 and December 17, 2019, inclusive (the “Class Period”). Trulieve investors have until…
DetailsLOS ANGELES–(BUSINESS WIRE)–The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Trulieve Cannabis Corp. (“Trulieve” or “the Company”) (OTC: TCNNF) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.…
DetailsBENSALEM, Pa.–(BUSINESS WIRE)–Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Trulieve Cannabis Corp. (“Trulieve” or the “Company”) (OTC: TCNNF) securities between September 25, 2018 and December 17, 2019, inclusive (the “Class Period”). Trulieve investors have until February 28, 2020 to file a…
DetailsNEW YORK–(BUSINESS WIRE)–Bragar Eagel & Squire, P.C., a nationally recognized shareholder law firm, reminds investors that a class action lawsuit has been filed in the United States District Court for the Eastern District of New York on behalf of investors that purchased Trulieve Cannabis Corporation (Other OTC: TCNNF) securities between September 25, 2018 and December…
Details